MRFF Grants 2020
MEDICAL RESEARCH FUTURE FUND (MRFF)
GRANT ANNOUNCEMENTS
The Government announced a $5 billion, 10-year investment plan for the Medical Research Future Fund (MRFF) as part of its 2019–20 Budget. This plan continues the support for life-saving research, provides researchers and industry with some certainty and direction, and re-affirms Australia’s reputation as a world leader in medical research.
Congratulations to three Neuroscience research trials initiated at The Royal Melbourne Hospital under the RMH Neuroscience Foundation, recipients of a significant MRFF Grant.
Stentrode | SWITCH Trial
– Prof Peter Mitchell, Dr Tom Oxley
Endovascular Brain Computer Interface for Independent Communication
“The trial focuses on an implantable brain computer interface, its application – a hands-free controller for personal computers and devices, helping to restore lost function to patients with severe paralysis, due to spinal cord injury, stroke, motor neuron disease and muscular dystrophy.”
MRFF Funding $1,481,180
Stroke | EVACUATE Trial
– Prof Bruce Campbell
A randomised controlled trial of ultra-early, minimally invasive surgery for intracerebral haemorrhage
MRFF Funding $2,138,226
Movement Disorders | Sodium Selenate for PSP Trial
– Prof Terry O’Brien, Dr Andrew Evans, Prof Dennis Velakoulis, Dr Charles Malpas
Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy
MRFF Funding $2,639,490
Thank you to The Hon Greg Hunt MP, Federal Minister for Health, for these MRFF Grant announcements.
$21.8 million for neurological disorders research
– 25 June 2020
A media release about a $21.8 million Australian Government investment in vital research that could mean major breakthroughs in treating
a range of neurological disorders, including early Alzheimer’s.
$29 million to tackle Nation’s biggest killers
– 5 June 2020
A media release about a $29 million investment in vital research initiatives to tackle the nation’s two biggest killers – heart disease and stroke.